Brenda Libby Coleman

Array ( [id] => 13647803 [patent_doc_number] => 09850203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-12-26 [patent_title] => Autotaxin inhibitor compounds [patent_app_type] => utility [patent_app_number] => 15/023465 [patent_app_country] => US [patent_app_date] => 2014-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56568 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 280 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11828709 [patent_doc_number] => 09725443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-08 [patent_title] => 'RORγ modulators' [patent_app_type] => utility [patent_app_number] => 15/022673 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19296 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 981 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9793547 [patent_doc_number] => 20150005492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-01 [patent_title] => 'STEREOSELECTIVE TOTAL SYNTHESIS OF NORIBOGAINE' [patent_app_type] => utility [patent_app_number] => 14/486804 [patent_app_country] => US [patent_app_date] => 2014-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7341 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14486804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12199670 [patent_doc_number] => 09902726 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-27 [patent_title] => 'Pyridone-sulfone morphinan analogs as opioid receptor ligands' [patent_app_type] => utility [patent_app_number] => 15/109161 [patent_app_country] => US [patent_app_date] => 2014-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26233 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15109161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10975401 [patent_doc_number] => 20140378437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-25 [patent_title] => 'AGENTS FOR TREATING DISORDERS INVOLVING MODULATION OF RYANODINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 14/475980 [patent_app_country] => US [patent_app_date] => 2014-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16536 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14475980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11678274 [patent_doc_number] => 09676790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'Substituted thienotriazolodiazapines' [patent_app_type] => utility [patent_app_number] => 14/915527 [patent_app_country] => US [patent_app_date] => 2014-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8176 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14915527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11963497 [patent_doc_number] => 20170267651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'TRPA1 AND TRPV4 INHIBITORS AND METHODS OF USING THE SAME FOR ORGAN-SPECIFIC INFLAMMATION AND ITCH' [patent_app_type] => utility [patent_app_number] => 15/505898 [patent_app_country] => US [patent_app_date] => 2014-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 21621 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15505898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11642193 [patent_doc_number] => 09663550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Method for preparing abiraterone acetate' [patent_app_type] => utility [patent_app_number] => 15/030018 [patent_app_country] => US [patent_app_date] => 2014-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3157 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11922632 [patent_doc_number] => 09790201 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-17 [patent_title] => 'Piperidine and azepine derivatives as prokineticin receptor modulators' [patent_app_type] => utility [patent_app_number] => 14/910377 [patent_app_country] => US [patent_app_date] => 2014-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40111 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14910377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822027 [patent_doc_number] => 20160168191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'PROCESS FOR THE PREPARATION OF ABIRATERONE OR ABIRATERONE ACETATE' [patent_app_type] => utility [patent_app_number] => 14/908721 [patent_app_country] => US [patent_app_date] => 2014-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4369 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14908721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11642195 [patent_doc_number] => 09663551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-05-30 [patent_title] => 'Solanidine-derived compounds' [patent_app_type] => utility [patent_app_number] => 14/905928 [patent_app_country] => US [patent_app_date] => 2014-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 16638 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14905928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9858684 [patent_doc_number] => 20150038701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'PROCESSES FOR THE PREPARATION OF 8-CHLORO-1-METHYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE AND INTERMEDIATES RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 14/321342 [patent_app_country] => US [patent_app_date] => 2014-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10721 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14321342 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408926 [patent_doc_number] => 09556218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Process for the preparation of abiraterone and intermediates thereof' [patent_app_type] => utility [patent_app_number] => 14/315642 [patent_app_country] => US [patent_app_date] => 2014-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 22 [patent_no_of_words] => 12596 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14315642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10968173 [patent_doc_number] => 20140371206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-12-18 [patent_title] => 'BROMODOMAIN INHIBITORS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/313148 [patent_app_country] => US [patent_app_date] => 2014-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67844 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14313148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11858953 [patent_doc_number] => 09738624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-22 [patent_title] => 'Nuclear transport modulators and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/900469 [patent_app_country] => US [patent_app_date] => 2014-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 42265 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14900469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11794027 [patent_doc_number] => 09403776 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin' [patent_app_type] => utility [patent_app_number] => 14/304833 [patent_app_country] => US [patent_app_date] => 2014-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 217103 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14304833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10940017 [patent_doc_number] => 20140343039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'PROCESS FOR PREPARING CEPHALOTAXINE ESTERS' [patent_app_type] => utility [patent_app_number] => 14/297736 [patent_app_country] => US [patent_app_date] => 2014-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7796 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14297736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10920447 [patent_doc_number] => 20140323467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'THERAPEUTIC COMPOUNDS AND COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 14/286088 [patent_app_country] => US [patent_app_date] => 2014-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 70 [patent_no_of_words] => 87219 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14286088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739322 [patent_doc_number] => 20140275042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'TRICYCLIC AND TETRACYCLIC SYSTEMS ACTING UPON THE VASCULAR AND CENTRAL NERVOUS SYSTEMS' [patent_app_type] => utility [patent_app_number] => 14/282111 [patent_app_country] => US [patent_app_date] => 2014-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 9291 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14282111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10761838 [patent_doc_number] => 20160107991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-21 [patent_title] => 'PROCESSES AND INTERMEDIATES FOR PREPARING INDOLE PHARMACEUTICALS' [patent_app_type] => utility [patent_app_number] => 14/890514 [patent_app_country] => US [patent_app_date] => 2014-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8711 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14890514 [rel_patent_id] =>[rel_patent_doc_number] =>)